Submitted by Anonymous (not verified) on 19 August 2025 - 17:00
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Date of authorisation: 14/08/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Usymro, ustekinumab, Date of authorisation: 14/08/2025, Status: Authorised